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link between blood pressure and intraocular pressure is 
of particular interest, especially in cases of low tension 
glaucoma2. Evidence from large-scale studies such as the 
Barbados Eye Study3, Baltimore Eye Study4 and the Sin-
gapore Malay Eye Study5, suggests that blood pressure 
plays a role in OAG progression. Rotterdam Eye Study6 
demonstrated an increased risk of OAG for patients with 
elevated blood pressure treated with calcium channel 
blockers specifically after 6.5 years of follow-up. This find-
ing is interesting because calcium channel blockers reduce 
blood pressure but not IOP, while systemic beta-blockers 
affect perfusion pressure to a lesser degree because they 
cause both a reduction in blood pressure and IOP. The 
evidence linking hypotension and glaucoma is more con-
sistent and the majority of studies suggest that hypoten-
sion, particularly nocturnal hypotension should be consid-
ered an important risk factor for the development and 
progression of glaucoma, particularly with regard to nor-
Intraocular pressure (IOP) is the most important risk 
factor for open angle glaucoma (OAG) onset and progres-
sion and currently the only risk factor amenable to modi-
fication by the ophthalmologists. However, there are limi-
tations to treating IOP including the fact that many 
glaucoma patients do not have a statically elevated pres-
sure, many patients with elevated IOP never develop glau-
coma and many patients continue to progress despite good 
control of IOP1. Although open angle glaucoma has an un-
known etiology, glaucomatous optic neuropathy could be 
also an ischemic optic neuropathy. In fact, the »vascular 
hypothesis« is based on the premise that abnormal ocular 
perfusion pressure plays a major role in the pathogenesis 
of glaucoma. Ocular perfusion pressure (OPP) is defined 
as the difference between the arterial blood pressure and 
the intraocular pressure (IOP), which is considered a sub-
stitute for the venous pressure. IOP-independent mecha-
nisms contribute to disease onset and progression and the 
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A B S T R A C T
The aim of this study is to determine relationship between glaucoma progression and diastolic blood pressure. It was 
conducted on 64 glaucoma patients at the Department of Ophthalmology of Clinical Hospital Centre Zagreb in three years 
period. The patients were on anti glaucoma therapy and had mean intraocular pressure values under 20 mmHg. At the 
same time they were on antihypertensive drug therapy. Patients were classified according Glaucoma Staging System based 
on the perimetric indices mean deviation (MD) and Pattern Standard Deviation into stage 2–4 (moderate glaucoma) at 
baseline. Rate of visual field progression was calculated in db/year for MD in the last three visits. Patients were divided 
in 3 groups according to progression – stabile, moderate and progressive. There was no statistically significant difference 
between 3 groups in terms of intraocular pressure values at baseline and in follow up period. After reviewing their blood 
pressure, the progressive group showed a significantly lower diastolic blood pressure compared to both stable group and 
the group with moderate progression. There was no statistical difference between the group with moderate progression 
and the stable group in terms of diastolic blood pressure. Results suggest that greater risk of glaucoma progression is 
connected with lower diastolic blood pressure. Diastolic pressure values could be important as one of the risk factors for 
progression in glaucoma patients with controlled intraocular pressure values.
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mal tension glaucoma. Many studies have found nocturnal 
blood pressure levels to be significantly lower in both nor-
mal tension glaucoma patients and progressive glaucoma 
patients, suggesting a possible causative link7,8. Further-
more, a large number of studies9,10 have found associations 
between large nocturnal dips in blood pressure (>20%) 
and the progression of glaucoma.
Some large-scale studies have found an increased risk 
of OAG with diastolic perfusion pressure (DPP) lower 
than 55 mmHg11,12.
Purpose of our study was to determine relation be-
tween glaucoma progression and the level of diastolic 
blood pressure in open angle glaucoma patients with med-
ically treated systemic hypertension.
Material and Methods
64 glaucoma patients with systemic hypertension at 
the Department of Ophthalmology University Hospital 
Centre Zagreb met inclusion criteria for this study. All 
patients had moderate glaucoma stage 2–4 accordingly to 
Glaucoma Staging System (GSS)13 with mean intraocular 
pressure values under 20 mmHg obtained with one or two 
anti glaucoma drugs. At the same time they were on anti-
hypertensive drug therapy. There were 62.17% male and 
54.17% female, mean age 65.32 for men and 62.45 for 
women. There was no statistical difference in sex and age 
distribution. Follow up period was 3 years. Patients were 
observed every 6 months and visual fields were performed 
once or twice a year. Intraocular pressure, central corneal 
thickness, blood pressure measurement (right arm sitting) 
were performed at each visit. Diastolic perfusion pressure 
(DPP) was calculated by equation for DPP (DPP=DBP–
IOP)14. Standard automated perimetry (SAP) Haag-Stre-
it Octopus 900/G2 glaucoma program was used. Glauco-
matous progression was defined on the basis of visual field 
change determined with SAP. The Glaucoma Staging Sys-
tem (GSS)13 was used for visual field defect classification 
at baseline. All included patients were classified according 
Glaucoma Staging System based on the perimetric indices 
mean deviation (MD) and Pattern Standard Deviation 
(PSD) into stage 2–4 (moderate glaucoma). The represen-
tative point of the examination is placed in a chart in ac-
cordance with the values of these indices. The chart shows 
defined areas for the different stages of disease (Stage 0 
– Stage 5). It also separates generalized, localized and 
mixed defects. Rate of visual field progression was calcu-
lated in db/year after 3 years of follow up. Patients with 
progression up to 0.2 db/year were considered stable, 0.2–
0.4 moderate and rate of progression more than 0.4 db/
year was considered rapid.
Data are presented as mean ± standard deviation. The 
comparison of stable and progressive group was done us-
ing Student’s t test. A probability lower than p<0.05 was 
considered statistically significant.
Results
Analyzing the visual field findings in 64 glaucoma pa-
tients in 3 year of follow up period, we classified 23 
(35.93%) patients with progression: 11 (17.18%) patients 
in progressive group with progression more than 0.4 db/
year and 12 (18.75%) patients in moderate progression 
group within 0.4 db/year of progression. 41 (64.06%) pa-
tients did not have marked progression in visual field (0.2 
db/year or less) (Figure 1). There was no statistically sig-
nificant difference between 3 groups in age. In terms of 
gender, in the progression group there were predominant-
ly women – 7 (63.64%) and 4 (36.36%) men. In the moder-
ate progression group gender ratio was 1:1, and in the 
stable group we found higher percentage of men (62.17%). 
There was no statistically significant difference between 
3 groups in terms of mean intraocular pressure values at 
baseline and in follow up period (Table 1).
After reviewing their blood pressure, the progressive 
group showed a significantly lower diastolic blood pres-
sure compared to both stable group and the group with 
moderate progression. Mean diastolic blood pressure in 
progressive group was low – 65.62±4.32 in comparison 
with mean diastolic pressure in the stable group – 
84.54±5.99 and this difference was statistically signifi-
cant. There was no statistically significant difference be-
tween the group with moderate progression and the stable 
group in terms of diastolic blood pressure. Congruently, 
TABLE 1
DEMOGRAPHIC CHARACTERISTICS, IOP, CCT, DBP, DPP
Stable (N=41) Moderate (N=12) Progressive (N=11) Significance level
% male 62.17 54.17 36.36
Mean IOP at baseline
16.88±3.13
17.43±2.17
16.33±4.00
16.29±3.46
16.91±2.89
16.47±3.15
p=0.74
p=0.72
Mean IOP in 3 years 552.79±37.53 542.59±43.11 540.12±36.52 p=0.33
Mean CCT 84.54±5.99 72.87±6,57 65.62±4.32 p<0.01
Mean DBP 65.63±5.43 54.72±6.87 47.33±5.87 p<0.01
Mean DPP   65.43±12.03   59.35±14.23  61.58±10.47 p=0.87
IOP – intraocular pressure, DBP – diastolic blood pressure, CCT – central corneal thickness, DPP – diastolic perfusion pressure
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mean diastolic perfusion pressure was statistically sig-
nificantly lower in progressive group compared with stable 
group (Table 1).
Discussion
Although high blood pressure has been shown to be 
associated with OAG14, low ocular perfusion pressure and 
low systolic blood pressure are also known risk factor for 
OAG. There are many evidences from studies that noctur-
nal hypotension plays a role in the development and pro-
gression of glaucoma15–18. This bimodal distribution of risk 
factors (both high and low blood pressure demonstrates 
some of the challenges in studying the relationship of glau-
coma and blood pressure19,20.
Findings from our study support the results of the Bar-
bados Eye Study3 that diastolic perfusion pressure under 
55 mmHg more than doubled the risk of OAG. Observa-
tions that decreased blood flow is found in OAG but not in 
patients with ocular hypertension and matched IOP indi-
cates a reduction in choroidal and short posterior ciliary 
artery circulation in primary open angle glaucoma19. This 
is in line with the findings of this study, because increased 
IOP with raised diastolic blood pressure could potentially 
result in adequate diastolic perfusion pressure as in stable 
group of our patients. Congruently, many studies have 
found that lower diastolic perfusion pressure essentially 
equates to a higher risk for OAG: Baltimore Eye Study4, 
Egna-Neumarket Study14, Barbados Eye Study3 and the 
Rotterdam Eye Study6.
The Barbados Eye Study3 showed that diastolic perfu-
sion pressure may be an important factor for classifying 
a patient as progressing with 2.6 times higher relative 
risk, compared to all other factors examined (age 1.1 
times; family history 2.4 times; higher IOP 1.1 times; sys-
tolic blood pressure 0.8 times; and CCTs 1.4 times).
An association between the degree of nerve fiber layer 
loss (using optical coherence tomography) and the time of 
day that hypertensive medication was administered (in 
the evening as opposed earlier in the day)21 was shown in 
glaucoma patients in 24-hour blood pressure profiles. This 
effect was suggested to potentially arise from greater noc-
turnal dips in blood pressure when medications were 
taken later in the day.
Lower diastolic pressure is found in open angle glau-
coma patients predominantly in the study with 24 healthy 
individuals and 29 open angle glaucoma patients who un-
derwent intraocular pressure and blood pressure mea-
surements every 2 h, starting at 08:00 until 06:00 of the 
next morning21. This is in agreement with finding from 
our study where mean diastolic blood pressure was shown 
to be an important risk factor for OAG progression. Mean 
diastolic blood pressure value in the group of progressive 
glaucoma patients was 65.62±4.32 mmHg, which was sta-
tistically significantly lower in comparison with diastolic 
blood pressure values in glaucoma patients without pro-
gression. The notion that reduced diastolic perfusion pres-
sure potentially impairs ocular blood blow in the absence 
of auto regulation has been suggested in some studies22,23.
As lower diastolic blood pressure can decrease ocular 
perfusion, there are likely clinical ophthalmic complica-
tions associated with medical intervention for hyperten-
sion. Although lowering of blood pressure is justified in 
terms of reducing cardiovascular risk, extra consideration 
should be extended to patients on glaucoma therapy or 
with ocular hypertension to ensure that perfusion pres-
sures are not reduced to the point of creating ischemia to 
the optic nerve. Consistently, aggressive treatment of hy-
pertension has been shown in some cases to cause serious 
damage to both the heart and brain24,25.
Although controversial, it is of interest to note, that 
ar terial hypertension actually appears to be a protective 
factor in glaucoma in some epidemiological studies26,27. 
There is necessity for close collaboration between glauco-
matologists and primary care physicians regarding the 
patient’s diastolic blood pressure values in the overall 
management of glaucomatous optic neuropathy.
Conclusion
Patients with progressive glaucoma at “normal” IOP 
remind us of the fact that other glaucoma risk factors be-
sides intraocular pressure could be important. If non-IOP 
related factors such as low blood pressure are contributing 
to progression in these patients, we may be exposing our 
patients to undue risk with further intraocular pressure 
lowering which may require aggressive intervention such 
as surgery. If ocular perfusion pressure is one of the final 
common pathways linking low blood pressure to glaucoma 
risk, then lowering IOP, which also improves ocular perfu-
sion pressure, would still be expected to reduce the risk 
from low blood pressure. Aggressive treatment of arterial 
hypertension should be avoided because it can lead to low 
diastolic blood pressure and consequently low perfusion 
pressure. Additional research is needed in both of these 
areas to provide new treatment strategies for clinicians.
Fig. 1. Percentage of visual field progression in 64 glaucoma 
patients in 3 years follow up period: stable (64.06%), moderate 
progression (18.75%) and progressive (17.18%).
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UTJECAJ DIJASTOLIČKOG KRVNOG TLAKA NA PROGRESIJU GLAUKOMA KOD PACIJENATA S 
GLAUKOMOM I SUSTAVNOM HIPERTENZIJOM
S A Ž E T A K
Cilj ove studije je utvrditi povezanost između progresije glaukoma i dijastoličkog krvnog tlaka. Studija je provedena 
na 64 pacijenata s glaukomom pri Klinici za očne bolesti KBC Zagreb u trogodišnjem periodu. Pacijenti su bili na anti-
glaukomskoj terapiji i imali su srednje vrijednosti očnogi tlaka ispod 20 mmHg. Istovremeno su bili i na antihiperten-
zivnoj medikamentoznoj terapiji. Pacijenti su u početku klasificirani prema Glaucoma Staging System, koji se zasniva 
na srednjoj devijaciji perimetrijskih indeksa (MD) i Obrascu standardne devijacije, u stadij 2–4 (umjereni glaukom). 
Stupanj progresije vidnog polja je izračunat u db/godina za MD u posljednja tri posjeta. Pacijenti su podijeljeni u tri 
skupine – stabilni, umjereni i progresivni. Nije nađena statistički značajna razlika između tri skupine u odnosu na očni 
tlak u početku i periodu praćenja. Nakon analiziranja njihovog krvnog tlaka, progresivna skupina pokazala je značajno 
niži dijastolički krvni tlak u odnosu na stabilnu i skupinu s umjerenom progresijom. Nije bilo statističke rzlike između 
skupine s umjerenom progresijom i stabilne skupine u odnosu na dijstolički krvni tlak. Rezultati upućuju na to da je 
veći rizik od progresije glaukoma povezan s nižim dijastoličkim krvnim tlakom. Vrijednosti dijastoličkog krnog tlaka 
mogle bi biti značajne kao jedan od čimbenika rizika za progresiju kod pacijenata s glaukomom i kontroliranim vrijed-
nostima očnog tlaka.
